Related Experiment Video

Updated: May 30, 2025

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.7K

Human Metapneumovirus: an emerging respiratory pathogen and the urgent need for improved Diagnostics, surveillance,

Adewunmi Akingbola1, Abiodun Adegbesan2, Samuel TundeAlao3

  • 1Department of Public Health and Primary Care, University of Cambridge Old Schools, Cambridge, UK.

Infectious Diseases (London, England)
|January 25, 2025
PubMed

Insights

Human Metapneumovirus (HMPV) causes severe respiratory illness globally, especially in vulnerable groups. Enhanced surveillance, diagnostics, and treatments are crucial for managing this re-emerging pathogen.

Area of Science:

  • * Infectious Diseases
  • * Public Health
  • * Virology

Background:

  • * Human Metapneumovirus (HMPV) is a significant re-emerging respiratory pathogen identified in 2001.
  • * It causes substantial morbidity and mortality, particularly in young children, the elderly, and immunocompromised individuals.
  • * HMPV transmission occurs via droplets, direct contact, and contaminated surfaces, amplified in crowded settings and healthcare facilities.

Purpose of the Study:

  • * To review the current understanding of HMPV epidemiology, clinical manifestations, and transmission dynamics.
  • * To highlight challenges in HMPV diagnosis and the lack of approved vaccines or antiviral therapies.
  • * To emphasize the need for enhanced surveillance, scalable diagnostics, and research into novel interventions.

Main Methods:

  • * Comprehensive literature review of HMPV research, focusing on epidemiology, clinical features, and transmission.
  • * Analysis of diagnostic challenges, including limitations in low-resource settings.
  • * Examination of current preventive strategies and emerging therapeutic and vaccine development.

Main Results:

  • * HMPV is a leading cause of acute respiratory tract infections (ARTIs) worldwide, with symptoms overlapping with other respiratory viruses.
  • * Diagnosis is complicated by symptom overlap and limited accessibility of advanced molecular tools in many regions.
  • * No specific vaccines or antiviral treatments are currently approved, necessitating reliance on general preventive measures.

Conclusions:

  • * There is an urgent need for improved global surveillance and accessible diagnostic tools for HMPV.
  • * Intensified research into effective vaccines and targeted antiviral therapies is critical.
  • * Addressing these gaps will mitigate the global burden of HMPV and enhance preparedness for respiratory virus outbreaks.
Keywords:
Human Metapneumovirus (HMPV)diagnosticsimmunocompromised populationsrespiratory infectionssurveillancevaccines

More Related Videos

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR11:00

High-throughput Detection of Respiratory Pathogens in Animal Specimens by Nanoscale PCR

Published on: November 28, 2016

11.9K
An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay09:14

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

10.7K

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
151
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
296